 |
|
|
|
| On the basis of a positive appraisal
of the 2006-2009 results and the conclusions of the economic
study of health biotechnology and medical technology
in Wallonia, BioWin has determined its strategic and
operational ambitions in line with the Marshall Plan
2. Green. |
|
|
|
|
 |
|
|
|
In the framework of the Marshall
Plan 2.Green, BioWin will continue to place the emphasis
on the development of Walloon SMEs in the health sector.
To that end, the cluster unveiled at a press conference
on 2 April last its strategic guidelines for the period
2010-2014, based on four main lines of actions:
- via its innovation support activities, to continue
to support excellence while satisfying itself that
the technologies and products developed meet market
needs and can be marketed as quickly as possible;
- to ensure that the supply of competences
matches as closely as possible the needs of companies
in the health sector;
- to pursue BioWin’s internationalisation policy,
on behalf of industry and SMEs in particular;
- to promote
the creation of the technological platforms and infrastructures
necessary for the development of the bio-medical sector
in the Walloon Region.
BioWin has determined its strategic
and operational goals on the basis of the positive evaluation
of its 2006-2009 results and the economic study on health
biotechnology and medical technology in Wallonia carried
out by Jean-Louis Mentior (CEO of M5) and his team. This
study provides in particular details of the jobs created
and the economic development generated, on the basis of
factual data, such as the annual accounts of 68 innovative
companies that are BioWin members, for the period from
1999 to 2008.
The
study’s main conclusions |
|
| |
|
|
 |
|
|
|
| An information session at the Parc
Créalys and a mission in the framework of the universal
exhibition in Shanghai. That is the programme developed
by BioWin for the coming weeks to help our companies
grasp the potential of the Chinese market. |
|
|
|
|
 |
|
|
|
Attracted by the Chinese market’s potential,
some companies have already decided to take the plunge.
Alongside big names such as GlaxoSmithKline Biologicals
which has invested substantially in Shanghai and Shenzhen,
several SMEs have already established contacts locally.
Thus, DNAVision and BGI-HK (Beijing Genomics Institute-Hong
Kong) unveiled, on 23 November last, a strategic partnership
intended to strengthen their position in the area of new
generation sequencing. Analis is in the process of forming
a partnership with a school of Chinese traditional medicine.
And it4ip wants to set up a research laboratory in Suzhou.
These examples illustrate the internationalisation capacity
of our companies.
BioWin intends to play a role in facilitating the initiatives of companies wanting
to expand on the Chinese market. If you are looking for such growth opportunities,
you will be interested in two important events we are organising in Belgium and
China.
Discover
our two mettings. |
|
| |
|
|
 |
|
|
|
| Stagesdespôles is the new platform
of the five Walloon competitiveness clusters in partnership
with colleges of higher education to match supply and
demand between companies and students for in-company
training to support technological innovation. |
|
|
|
|
|
This new platform, which
has been operational on the Internet since 31 March,
was launched in the framework of the Clusters In-Company
Training project which was set up in October 2009. The
new platform is the fruit of the cooperation between
the five Walloon competitiveness clusters (BioWin, Skywin,
Wagralim, Mecatech and Logistics in Wallonia) in partnership
with colleges of higher education to match supply and
demand between companies and students in the framework
of in-company training to support technological innovation
in the French Community of Belgium.
This in-company training is intended for students nearing
the end of their university or higher education studies
in scientific, technological or management fields. The
objective of the project is to develop a series of practical
competences sector among future higher education graduates
to facilitate their integration into the sectors of economic
activity supported by the five clusters, namely health
biotechnology, aeronautics and space, agribusiness, mechanical
engineering and logistics.
In order to facilitate their integration into employment
and increase the autonomy of the students receiving in-company
training, new modules focusing on industrial themes (quality,
project management etc.) will be added to the project on
an ongoing basis. At the current time, two training programmes
are available: discovering the quality system of bioindustries
and best validation practices, and raising awareness about
the management of technological innovation projects.
www.stagesdespôles.be |
|
| |
|
|
|
|
|
|
|
Belgian
Breakfast meeting at the BIO convention in Chicago
|
|
|
 |
Belgium
will be present at the BIO conference in Chicago (3-6 May),
an international convention which brings together all key biology
and biotechnology stakeholders. The Walloon wing of the delegation
will be located on stand 4805 of the Belgian pavilion.
Alongside the convention, the three regions have invited
international companies to a Belgian Breakfast Meeting.
On 4 May, alongside a Belgian delegation composed of around
twenty Walloon organisations and companies, the three main
French-language universities and representatives of the
Federal government and the Walloon research administration,
key personalities will address the meeting to explain why
global companies are investing in the biotechnology sector
in Belgium.
In the evening of 4 May, the Belgian Café evening, which had
attracted more than 800 people last year, will be held in the
bar where Buddy Guy, a big name in the blues world, will delight
blues lovers. A presence will also be assured at the convention. |
| |
 |
|
FlandersBio
invites you to its annual convention
|
|
|
This
convention will be held at the ICC Ghent on 20 May next. On
the theme “Collaboration, Driving Innovation Forward”, the
presentations will focus on innovations in the area of medicine
and health, but also on plant and industrial biotechnology
companies.
BioWin will make a presentation in the framework
of the Bio-ExTRAKT programme put in place by FlandersBio to
bring together, via networking activities, companies and organisations
from Flanders’ neighbouring biotechnological regions.
For more
information, to attend the presentations and/or visit the stands, www.knowledgeforgrowth.be |
| |
 |
|
Rendezvous
in Bangalore with the AWEX
|
|
|
|
Join
the Awex group of companies and research centres which will participate
on 2-4 June next in the Bangalore India Bio 2010 conference,
the leading Indian event in the biotechnology sector.
A not-to-be
missed networking opportunity, since it should be borne in mind
that the Indian biotechnology sector is the third largest in
Asia, with estimated annual growth of 30% while the sector’s
revenues are expected to reach 5 billion US dollars in 2010.
At the same time, India recognises the need for international
cooperation to ensure that the biotechnology sector continues
to grow.
For more information and to take advantage of very attractive
participation terms, contact Catherine Collet, Project Manager
Asia Pacific Export & Investment at AWEX (c.collet@awex.be).(c.collet@awex.be). |
| |
 |
|
